We examined the effects of maternal dietary protein restriction on fetal growth and expression of IGF-I and -11, and ' IGF-binding proteins (IGFBP). We sought to dissociate the , respective effects of maternal protein versus calorie restriction on growth indices and IGF synthesis by the neonates of proteinrestricted dams. Pregnant Wistar rats (six to eight per group) fed a low (5%) protein diet throughout gestation had impaired body weight gain compared with controls fed a normal (20%) protein diet (by 45%, p < 0.001). Their serum and liver IGF-I concentrations and liver IGF-I mRNA concentrations were also reduced by 60, 80, and 50%, respectively. Serum IGFBP-3 was reduced by 60% in protein-restricted dams within 1 to 2 h after delivery ( p < 0.001 versus controls), although IGFBP-1, -2, and -4 were not significantly affected by the dietary protein intake. In pups of ' protein-restricted dams, the mean body and liver weight at birth was 15-20% less than that observed in the progeny from normal protein-fed dams ( p < 0.01). Their plasma and liver IGF-I concentrations were 30 and 60% lower, respectively, whereas
/
We examined the effects of maternal dietary protein restriction on fetal growth and expression of IGF-I and -11, and ' 
IGF-binding proteins (IGFBP)
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In contrast, neonatal plasma IGF-I1 and liver IGF-I1 mRNA concentrations wen: not significantly affected by the maternal protein malnutrition. Also, the plasma levels of IGFBP were not altered in the growlh-retarded pups. Maternal protein restriction did not affect fetal and placental growth, plasma and liver IGF-I levels, and liver IGF-I mRNA abundance in 20-d-old fetuses. We conclude that intrauterine growth retardation caused by maternal protein malnutritior~ is associated with reduced neonatal expression of the IGF-I gene without obvious changes in IGF-I1 gene expression and plasma IGFBP concentrations. These results support the emerging !evidence that IGF-I may play a role in the regulation of fetal growth and development. (Pediutr Res 37: 3 3 4 4 2 , 1 9 9 5 ) Abbreviations IGFBP, IGF binding protein GH, growth hormone ANOVA, analysis of variance IUGR, intrauterine growth retardation BW, body weight IGF-I and IGF-I1 promote growth during postnatal life (1) . There is also evidence that the IGF may regulate fetal growth and differentiation. IGF and their mRNA are present in most fetal tissues (2-4); specific IGF receptors and IGFBP are widely expressed during fetal life (5); and IGF exert mitogenic 21). Decreased serum IGF-I and increased liver IGFBP-1 mRNA are also observed in growth-retarded fetuses after maternal uterine artery ligation (7) or fasting (9). Nutrition, however, does not appear to influence fetal IGF-I1 expression (7, 8) .
Maternal protein restriction stunts fetal somatic and organ growth (22), and reduces fetal serum IGF-I concentrations (23). In our study, we examined the effects of maternal dietary protein restriction on growth, plasma IGF-I, IGF-11, and IG-FBP, and on liver expression of the IGF genes in fetal rats at two different times of gestation-2 d before delivery and at birth. Because preliminary experiments showed that proteinrestricted dams decrease their food intake during late gestation, we sought to dissociate the respective effects of maternal protein versus calorie restriction on the growth indices of the neonates.
METHODS

Animals.
Pregnant Wistar rats (dams) were purchased from KUL laboratories (Leuven, Belgium). The day of initiation of pregnancy was determined by the presence of a vaginal plug after overnight mating, and was designated as d 0 of gestation. Upon arrival at d 0, the rats were weighed (initial BW: 210-230 g) and randomly assigned to one of two powdered diets: a normal protein diet (20% casein; P20) or a low protein diet (5% casein; P5; U.A.R., Villemoisson-sur-Orge, France). Both diets were isocaloric (325 ca1/100 g) and contained similar amounts of fat (5%), cellulose (17%), and essential minerals and vitamins (8%). Animals were housed individually in metabolic cages under controlled conditions of lighting (0600-1800 h) and temperature (22 + 2"C), and had free access to tap water. BW and food intake were recorded daily, and dams that failed to gain weight normally were excluded from the studies. Near parturition (d 22 of gestation), dams were observed every 1-2 h to determine the time of delivery accurately.
Experimental design. In experiment 1, dams were fed ad libitum either the normal protein diet (P20; controls; n = 6) or the low protein diet (P5; n = 7) throughout gestation until delivery (d 22 of gestation).
In experiment 2, dams were also fed ad libitum either the control diet (P20; controls; n = 9) or the protein-restricted diet (P5; n = 8) until d 20 of gestation. They were killed at that time and the fetuses were removed by cesarean section.
In experiment 3, dams were divided into three groups. The first group (P20; controls; n = 6) was fed the normal protein diet ad libitum throughout gestation. The two other groups (pair-fed groups) received either the normal protein diet (PF20 group; n = 6) or the low protein diet (PF5 group; n = 8) in isocaloric amount. This quantity was determined daily from the group of rats having the lowest food consumption (PF20 group from d 0 to 17; PF5 group from d 18-22). Dams and their corresponding litters were killed by decapitation, either on d 20 of gestation (experiment 2) or within 1-2 h after parturition (experiments 1 and 3). Each fetus or neonate was quickly weighed and dissected. Blood was collected from trunk vessels into glass tubes for dams or heparinized tubes for litters. Serum or plasma was stored at -20°C until assayed for IGF-I and IGF-11. Maternal livers and placentas and fetal or neonatal livers were removed and weighed. The number of fetuses or neonates in each litter was recorded, and plasma and livers were each pooled to provide one sample per litter. One fragment of each liver sample was quick-frozen in liquid nitrogen and stored at -70°C for later determination of IGF-I content and mRNA studies. The remaining portion of the liver was homogenized in ice-cold 0.3 M sucrose (lo%, wtlvol) buffered at pH 7.4 with 3 mM imidazole-HC1 as described previously (24). The homogenates were stored at -20°C until assayed for protein and DNA contents by the methods of Lowry et al. (25) and Karsten and Wollenberger (26), respectively. This study was approved by the Institutional Animal Care and Use Commitee of the University of Louvain at Brussels.
RIA. Immunoreactive IGF-I and IGF-I1 were measured in serum or plasma using a nonequilibrium RIA (24, 27). Values are reported in ng/mL using pure plasma-derived human IGF-I or IGF-I1 as standard. IGFBP in dam sera were separated from IGF-I using the C18 Sep-pak cartridge (Waters Associates, Milford, MA) chromatography (27, 28). Because the C18 cartridge chromatography might not remove IGFBP from fetal plasma efficiently enough and the dose-response curves of the eluates were not parallel in the IGF-I1 assay, fetal samples were prepared for assay by acid Sephadex G-50 column chromatography (29). Rat GH was measured in a double-antibody RIA (24) using the reagents provided by the NIDDK Rat Pituitary Hormone Distribution Program. Results are expressed in terms of the National Institutes of Health RP-2 reference preparation. The RIA for serum/plasma insulin, using rat insulin as standard, was performed as described previously (24, 28), except that the second antibody was a solid-phase coupled antiguinea pig y-globulin (IRE, Fleurus, Belgium).
Measurement of liver IGF-I peptide concentrations. Liver IGF-I content was determined in dams and litters by RIA (24) after extraction using a method validated for rat tissues (30). Briefly, each liver sample (50-100 mg) was pulverized in a mortar and pestle under liquid nitrogen, mixed with 1 mL ice-cold 1.0 M acetic acid, vortexed vigorously, and incubated on ice for 2 h. After centrifugation at 20 000 X g for 30 min at 4"C, the supernatant was transferred to a polypropylene tube and the pellet was reextracted using the same procedure. Both supernatants were combined and dessicated in a speed-vac concentrator (Savant Instruments, Farmingdale, NY). The material was stored at -20°C and reconstituted in assay buffer 24 h before RIA. The Hb concentration was also measured by the cyanornethemoglobin method on aliquot of each liver extract reconstituted in Tris buffer, pH 7.4. The amount of IGF-I in the extract that could have been derived from blood contamination was subtracted from the total extractable IGF-I, as described previously (30). The results are expressed as ng of IGF-I per g tissue in terms of purified human plasma-derived IGF-I.
RNA preparation and Northern blot hybridization. Total RNA was extracted from the livers of dams (three to four animals per group) and fetuses or neonates (pooled livers from each litter; three to six litters per group) by the guanidine MUAKU thiocyanatelcesium chloride method (31). For litters, a poly(~)+ RNA-enriched preparation was isolated by three passages of total RNA (1500 pg) through an oligo(dT)-cellulose column. Total RNA (20 pg) or poly(A)+ RNA (15 pg) samples were size fractionated on forrnaldehyde/l% agarose gels, and transferred to nylon membranes (Hybond-N, Arnersham, Buckinghamshire, UK) by overnight vacuum blotting (VacuGene XL, Pharmacia LKB, Sweden). After UV cross-linking (Stratalinker, Stratagene, La Jolla, CA), the membranes were sequentially hybridized to rat [32~]-labeled complementary RNA probes specific for IGF-I and IGF-I1 mRNA, using prehybridization, hybridization, and washing conditions previously reported (18, 32).
The specific IGF-I antisense riboprobe was generated from the 194-bp AvaII-Hinfl rat IGF-I exon 3 complementary DNA fragment (33) inserted into the plasmid vector Bluescript (pBS M13+), using uridine 5'-[a-32~]triphosphate (Amersham; 800 Cilmmol), and T7 RNA polymerase. The 275-bp RsaI rat IGF-I1 exon 3 complementary DNA fragment (34) subcloned into the vector pBS ~1 3 + was linearized with EcoRI, and a specific 32~-labeled IGF-I1 antisense riboprobe was transcribed using T3 RNA polymerase. Hybridization with a chicken [32~]-labeled p-actin complementary DNA, kindly provided by Dr. D. W. Cleveland, was subsequently performed to estimate the variation in RNA loading. Blots were subjected to autoradiography at -70°C using Kodak X-AR films and intensifying screens. Abundance of hybridized mRNA was quantified by scanning of autoradiograms using an LKB Ultroscan XL laser densitometry scanner (LKB-Bromma, Sweden). The results were corrected for p-actin mRNA and standardized by assigning a value of 100 arbitrary units to hepatic mRNA from control animals. Each individual mRNA value was the mean calculated from two to four different blots run with the same liver RNA preparations.
Measurement of ZGFBP. To assess the abundance of serum1 plasma IGFBP, ligand blotting was performed as previously described (16) using PAGE. Electrophoresed proteins were transferred to nitrocellulose membranes that were incubated with a mixture of [ ' 2 5 ]~~~-~ and [ 1 2 5~]~~~-~~, 200 000 cpm/mL each, washed and subjected to autoradiography at -70°C. The autoradiograms were scanned using an LKB Ultroscan XL laser densitometry scanner (LKB-Bromma). For each sample, density signals were determined for the 45 000-39 000 M, (IGFBP-3), the 34 000-29 000 M, (IGFBP-1 and-2), and the 24 000 M, (IGFBP-4) bands. The 34 000-29 000 M, bands representing IGFBP-1 and -2 were analyzed together because they could not be reliably separated for quantification by scanning densitometry. The abundance of IGFBP in a pool of sera from normal-fed adult nonpregnant rats served as control. The sizes of radioactive protein bands were estimated by comparison to standards from Bethesda Research Laboratories (Gaithersburg, MD).
Statistical analysis. Data were analyzed by unpaired t test or by one-way analysis of variance, followed by the StudentNewman-Keuls test to compare multiple means. Data are presented as the mean 2 SEM, and p < 0.05 was considered significant.
RESULTS
E$ects of protein restriction throughout gestation on dams and newborn pups. Mean daily food intake on d 0-17 of gestation was approximately 20% higher in rats fed the low protein diet than in control rats (P5 versus P20; p < 0.05; Fig.   1A ). During the last 5 d of pregnancy, however, food consumption of the P5-fed dams decreased dramatically to 40% of the intake of the P20-fed dams ( p < 0.05). BW gain in P5-fed dams was impaired (45% decrease at term; p < 0.01 versus controls; Fig. lB) , and liver weight and liver protein content were decreased (Table 1) . Serum and liver IGF-I concentrations in the P5 dams were, respectively, 56 and 86% lower than in the P20 dams, whereas their liver IGF-I mRNA abundance was reduced by 50% (Table 1) . Among the circulating IGFBP assayed by ligand blotting, IGFBP-3 (45 000-39 000 M, band) was markedly reduced (by 60%) in the protein-restricted dams within 1-2 h after parturition ( p < 0.001 versus normal-fed dams), although IGFBP-1, -2, and -4 were not significantly affected ( Fig. 2A) .
Maternal protein restriction caused significant growth retardation in the newborn pups without affecting litter size. Body and liver weights of the pups from protein-restricted dams were 15-20% less than those from normal protein-fed dams ( p < 0.01; Table 2 ). The reduction in liver weight was predominantly the result of decreased cell number, as indicated by the decrease in the DNA content, without significant change in the protein/DNA ratio ( Table 2) . Maternal protein deprivation also reduced neonatal plasma and liver IGF-I concentrations, which were, respectively, 29 and 60% lower than in controls (Fig.  3B) . Total IGF-I mRNA abundance was decreased by 40% in the liver of pups from P5 dams (Fig. 3B) . All IGF-I mRNA species (7.5, 4.7, 1.7, and 1.2-0.7 kb) were decreased to a similar degree (Fig. 3A) . When compared with adult pregnant or nonpregnant (NL or normal) rats, the typical pattern of IGFBP in neonatal rat plasma included virtually no IGFBP-3, similar amounts of IGFBP-4, and higher levels of IGFBP-1 andlor -2 (29 000-34 000 M, band). Maternal protein deprivation during pregnancy did not influence significantly the relative abundance of the various IGFBP species (Fig. 2B) . Similar plasma insulin (1.06 + 0.5 and 1.02 + 0.1 ng/mL) and GH (71.8 + 7.7 and 80.0 + 4.9 ng/mL) concentrations were also observed in pups from control and malnourished mothers. Table   3 ). Serum and liver IGF-I concentrations and liver IGF-I mRNA abundance in P5 dams were decreased by 56, 84, and 46%, respectively (Table 3) . Similar relative concentrations of serum IGFBP-1 to -4 were found in control and proteinmalnourished dams, although serum IGFBP-3 levels in control dams were dramatically decreased compared with control nonpregnants rats (data not shown).
Maternal protein restriction from d 0-20 of gestation did not affect litter size nor indices of growth in 20-d-old fetuses, except for a 27% decrease in the fetal liver DNA content (Table 4 ). The mean placental weight was also similar among protein-restricted and normal-fed dams (0.57 ? 0.09 and 0.60 + 0.08 g in P5 and P20 dams, respectively). Fetal plasma and liver IGF-I concentrations as well as liver IGF-I mRNA levels were not affected by the maternal protein restriction until d 20 of gestation (Fig. 4) . There was also no significant change in fetal plasma IGFBP (data not shown).
Specific effects of maternal protein and calorie restriction on dams and newborn pups. In a third experiment, equivalent daily caloric intakes were ingested by dams fed the 20% (PF20) and the 5% (PF5) protein diet (55.6 + 2.6 and 55.0 2 2.6 calld, respectively) by first reducing the food consumption of the PF5 group during d 0-17 (by approximately 20%), and then by reducing the food consumption of the PF20 group during d 18-22 by approximately 40%. BW gain in PF20 dams remained similar to that of ad libitum P20-fed controls until d 18 and decreased during the last 4 d of pregnancy; it was 20% lower at term (94.5 + 4.6 versus 117.4 + 7.5 g; p < 0.05).
However, their liver weight and protein content were similar to the values found in controls (data not shown). The BW gain of dams fed the 5% protein diet (PF5) was markedly impaired; it was 42% less at term than that in PF20 dams (55.1 + 5.0; p < 0.001). There was also a 30% decrease of liver weight and protein content in the PF5 dams, compared with the PF20 values ( p < 0.01, respectively). No significant difference was observed in the serum and liver concentrations of IGF-I nor in the hepatic abundance of IGF-I mRNA between PF20 and P20 control dams (Fig. 5) . In contrast, in the PF5 dams, serum and liver IGF-I concentrations were severely reduced by 62 and 80%, respectively, compared with PF20 values, and liver IGF-I Litter size and indices of growth at birth in pups from dams fed a normtrl protein diet ad libitum (P20; controls) By comparing pups from normal protein pair-fed dams (PF20) with those from the ad libitum-fed controls (P20; controls), we could show that the sharp decline in the caloric intake of the rnothers during the last 4 to 5 d of pregnancy did not cause impitired growth (Table 5 ). There was also no change in the plasma IGF-I and IGF-I1 and liver IGF-I concentrations of the pups from PF20 dams, or in their liver IGF-I and IGF-I1 mRNA concer~trations (Table 5 and Fig. 6B ). By contrast, pups from PF5 dams exhibited severe reductions in BW (-18%), liver weight (-24%), and liver DNA and protein contents (Table 5 ). Plasma and liver IGF-I concentrations and liver IGF-I mRNA abundance at birth were decreased by 34,54, and 49%, respectively, in pups from PF5 dams compared with values in pups from PF20 dams (Fig. 6B) . All the major IGF-I mRNA species were decreased to the same extent (Fig. 6A) . In contrast, there was no influence of maternal protein restriction on neonatal plasma IGF-I1 and liver IGF-I1 mRNA concentrations (Table 5 ). Litter size was also similar among the three groups (nine pups per litter).
DISCUSSION
Our studies show that protein restriction in pregnant rats causes fetal growth retardation that is evident at birth (d 22), but not on d 20 of gestation. Similar effects on fetuses occurred when pregnant rats were fed an 8 or 7% protein diet throughout gestation (35, 36) . These time-dependent effects of maternal protein restriction may therefore reflect a progressive depletion of maternal nutrient stores, which results in an inability to keep pace with accelerated growth at the end of gestation. In other studies, pregnaint rats fed a 5% protein diet from d 7-20 of gestation had decreased food consumption and reduced fetal and placental weights at the end of this period, compared with controls (23, 3;'). Divergence between the latter findings and the apparent lack of effects we observed in 20-d-old fetuses might be explained by the increased food intake of our dams during the first : ! wk of pregnancy. During this anabolic phase of gestation, the protein increments in fetuses are insignificant, whereas the dam builds up a reserve of proteins (38) . Conversely, the last days of pregnancy, during which fetal effects of maternal protein deprivation become apparent, correspond to a period of rapid fetal growth and utilization of the maternal protein reserve (38) . The increase in food intake in pregnant rats fed the low protein diet ad libitum on d 0-17 and the reduction during the last 5 d (18-22 d) has been reported previously (39) . Thus, during the metabolic stress of pregnancy, availability of dietary proteins has a strong timedependent effect on food intake. The mechanisms for this are not understood. Table 3 . Cumulative BW gain, liver protein content, serum, and liver IGF-I concentrations and liver IGF-I mRNA abundance on d 20 of   gestation in dams fed a normal protein diet ad libitum (P20; controls) or a low protein diet (P5) during d 0-20 The possibility that lower birth weight in pups from proteinrestricted dams might be due to reduced maternal caloric intake during the last days of gestation, is excluded by our finding that a similar restriction of food intake in dams fed a normal protein diet did not reduce neonatal weight or other indices of growth. This indicates that the retarded growth of malnourished pups is due to protein and not caloric restriction, and confirms the report of Chiang and Nicoll (40) who showed that maternal caloric restriction during the last half of pregnancy does not adversely affect fetal growth or placental weight.
In normal fed rats, there is a dramatic decline in the serum concentrations of IGF-I during late pregnancy (41) . We showed that serum IGF-I concentrations are further reduced in dams subjected to protein malnutrition, and that this is due to protein rather than caloric restriction. At least two mechanisms may lead to decreased IGF-I during normal late gestation. First, there is a decrease in IGFBP-3, the principal IGF-I carrier protein in serum, associated with an increase in proteolysis of IGFBP-3 (41, 42) . This reduces the IGF-I bound in serum, and increases its degradation and clearance (40) . Second, steady state IGF-I mRNA and peptide levels in liver are decreased in 21-d pregnant rats, suggesting that there is decreased IGF-I synthesis (41) . Identical mechanisms operate in the regulation of IGF-I by dietary protein intake (16-19, 43, 44) . Low IGF-I levels in protein-restricted animals are due to reduced hepatic IGF-I mRNA transcription and/or stability (18, 19), increased serum IGF-I clearance and degradation (44) , and reduced serum IGFBP-3 concentrations (16,17,43). Thus, mechanisms operative during late pregnancy could become accentuated when the maternal dietary protein intake is deficient. In our study, serum and liver IGF-I peptide and mRNA levels are decreased in parallel in protein-restricted dams. In addition, in 20-d pregnant rats subjected to protein restriction, there is no further reduction of serum IGFBP-3, although their IGF-I is markedly reduced compared to normal-fed controls. Taken together, our results suggest that decreased liver IGF-I gene expression is likely the predominant mechanism for decreased serum IGF-I concentrations in the P5 dams. Our study, how- Values are given as the mean f SEM of six to eight litters per group, except for liver IGF-I1 mRNA determined on two separate blots performed with 15 p g of poly(A)+ mRNA from the pooled livers of a litter (n = 31group).
* p < 0.01 vs PF20 and P20. t p < 0.001 vs PF20 and P20. ever, cannot rule out a regulatory role of IGFBP-3 proteolysis, because proteolysis was not assessed directly. Moreover, the Western blot results are not sufficiently sensitive to discern subtle changes, and proteolyzed IGFBP-3 is virtually undetectable by IGF-1iga:nd blotting (45) .
The effects of maternal protein deprivation on fetal growth paralleled changes in circulating fetal IGF-I. Body and liver weights, and plasma IGF-I concentrations were not reduced in 20-d fetuses from malnourished dams, but were significantly decreased in newborn pups. Pilistine et al. (23) have also reported decreased serum IGF-I concentrations in the serum of the growth-retarded rat fetuses whose mothers were given a low (5%) protein diet for the last 2 wk of pregnancy. Similarly, IUGR in humans (12) and in several rat models of fetal growth retardation (6-11) is accompanied by decreased IGF-I in serum. Taken together, these findings suggest that reductions in IGF-I production and/or availability contribute to stunting of fetal growth. Consistent with this suggestion, are the results from recent studies of Liu et al. Other mechanisms that might account for reduced plasma IGF-I in the growth-retarded pups include reduction of fetal GH secretion, impaired IGF-I release from liver cells or decreased availabilf.ty of IGFBP. Reduced GH is an unlikely mechanism because IGF are not under GH control during fetal development, primarily because of receptor immaturity (46, 47) , although GH receptor mRNA and immunoreactivity are observed in fetal rat tissues as early as embryonic d 12 (48) . Clinical and experimental evidence also indicates that GH is not essential for fetal growth (49) , and that the major effect of GH on growth and IGF-I production occurs postnatally (50, 51) . Moreover, there was no significant difference in plasma GH concentratior~s between our control and growth-retarded newborn pups. A secretory defect of IGF-I from liver cells also seems unlikely, because there was no accumulation of IGF-I in
